Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:42AM ET
16.40
Dollar change
+0.23
Percentage change
1.42
%
Index- P/E- EPS (ttm)-35.16 Insider Own- Shs Outstand3.22M Perf Week2.97%
Market Cap52.97M Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.97%
Income-112.96M PEG- EPS next Q- Inst Own- Short Float- Perf Quarter61.14%
Sales1.16M P/S45.67 EPS this Y- Inst Trans-4.48% Short Ratio0.86 Perf Half Y-20.08%
Book/sh22.65 P/B0.72 EPS next Y- ROA-42.26% Short Interest0.02M Perf Year-8.89%
Cash/sh25.59 P/C0.64 EPS next 5Y-9.40% ROE-90.02% 52W Range8.24 - 26.64 Perf YTD49.85%
Dividend Est.- P/FCF- EPS past 5Y-0.07% ROI-154.76% 52W High-38.44% Beta-0.10
Dividend TTM- Quick Ratio7.25 Sales past 5Y199.24% Gross Margin-11.33% 52W Low98.93% ATR (14)1.08
Dividend Ex-Date- Current Ratio7.25 EPS Y/Y TTM-2264.74% Oper. Margin-7967.30% RSI (14)58.15 Volatility10.11% 6.29%
Employees7 Debt/Eq0.02 Sales Y/Y TTM-63.97% Profit Margin-9771.71% Recom3.00 Target Price27.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q53.43% Payout- Rel Volume1.75 Prev Close16.17
Sales Surprise0.00% EPS Surprise-35.71% Sales Q/Q-100.00% EarningsNov 14 AMC Avg Volume22.00K Price16.40
SMA200.54% SMA5014.87% SMA2000.30% Trades Volume14,308 Change1.42%
Date Action Analyst Rating Change Price Target Change
Jul-28-23Downgrade Robert W. Baird Outperform → Neutral $9 → $1.50
Feb-22-22Reiterated BTIG Research Neutral $35 → $29
Feb-22-22Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-22-22Downgrade Oppenheimer Outperform → Perform
Mar-02-21Initiated Stifel Hold $14
Dec-14-20Resumed H.C. Wainwright Buy $30
Aug-11-20Reiterated H.C. Wainwright Buy $37 → $30
Jun-25-20Resumed BofA/Merrill Buy $30
May-13-20Initiated RBC Capital Mkts Outperform $30
Mar-16-20Upgrade Oppenheimer Perform → Outperform $32
Mar-18-24 04:30PM
Mar-15-24 09:52PM
Mar-01-24 10:48AM
Jan-27-24 12:10PM
Jan-03-24 04:08PM
06:40AM Loading…
Nov-17-23 06:40AM
Nov-16-23 12:18PM
07:05AM
Nov-14-23 05:02PM
04:33PM
Aug-14-23 04:20PM
04:05PM
Jul-27-23 04:05PM
04:01PM
Jul-06-23 11:17AM
08:00AM Loading…
May-16-23 08:00AM
May-11-23 05:35PM
04:25PM
04:05PM
May-03-23 07:30AM
Mar-27-23 05:52AM
Mar-15-23 04:01PM
Mar-09-23 06:45PM
04:05PM
08:00AM
Mar-02-23 07:30AM
Feb-24-23 05:31AM
Feb-22-23 04:01PM
Jan-05-23 09:25AM
Jan-04-23 04:01PM
08:08AM Loading…
Nov-12-22 08:08AM
Nov-10-22 05:45PM
04:07PM
Oct-27-22 09:00AM
Oct-06-22 08:30AM
Sep-27-22 08:15AM
Sep-08-22 11:05AM
Sep-06-22 04:01PM
Aug-17-22 01:05PM
Aug-16-22 11:52AM
Aug-15-22 06:15PM
04:10PM
Aug-12-22 07:46AM
Aug-11-22 04:05PM
Jul-25-22 09:12AM
Jul-05-22 08:30AM
Jun-29-22 08:00AM
Jun-13-22 08:00AM
Jun-10-22 08:30AM
May-18-22 06:00AM
May-16-22 06:05PM
04:15PM
May-13-22 08:45AM
May-02-22 04:56PM
Apr-21-22 08:30AM
Mar-23-22 05:45PM
04:10PM
Mar-10-22 04:01PM
Mar-08-22 10:00AM
Mar-07-22 09:38AM
Mar-03-22 03:00PM
07:30AM
Feb-24-22 08:45AM
05:39AM
Feb-23-22 10:00AM
Feb-22-22 07:34AM
Feb-21-22 09:40AM
02:53AM
Feb-18-22 04:05PM
Feb-10-22 11:40AM
07:18AM
Feb-02-22 09:40AM
Jan-28-22 10:46AM
02:30AM
Jan-21-22 09:38AM
Dec-12-21 08:19AM
Dec-10-21 06:38PM
Nov-15-21 07:10AM
Nov-03-21 08:29AM
Nov-01-21 03:01PM
Oct-21-21 07:00AM
Oct-20-21 08:30AM
Oct-18-21 08:30AM
Oct-13-21 08:21AM
Oct-12-21 04:05PM
Oct-11-21 08:39AM
Aug-14-21 03:27AM
Aug-12-21 07:05PM
04:05PM
Aug-05-21 08:30AM
Aug-04-21 08:30AM
Aug-02-21 03:01PM
Jun-19-21 05:23AM
May-13-21 07:00AM
May-06-21 06:15PM
04:05PM
May-03-21 08:00AM
Apr-29-21 05:06PM
Apr-28-21 08:00AM
Apr-20-21 03:28AM
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TZIANABOS ARTHURDirectorJan 09 '24Sale0.5713,0377,445128,778Feb 15 04:33 PM
Alloway PaulSee RemarksJan 03 '24Sale0.577,2804,12028,036Jan 05 05:54 PM
Michaud Charles JrSee RemarksJan 03 '24Sale0.571,70897511,598Jan 05 05:49 PM
Seymour AlbertSee RemarksSep 06 '23Sale1.151,4481,665150,874Sep 08 04:44 PM
Jordan JulieChief Medical OfficerAug 03 '23Option Exercise0.006,57908,804Aug 07 09:39 PM
Jordan JulieChief Medical OfficerAug 03 '23Sale1.391,8532,5763,882Aug 07 09:39 PM
Jordan JulieChief Medical OfficerAug 02 '23Option Exercise0.0035002,869Aug 04 04:08 PM
Jordan JulieChief Medical OfficerAug 02 '23Sale1.31991302,770Aug 04 04:08 PM